This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
J

ESMO 2024 Insights: Final OS From the ATALANTE/ENGOT-ov29 Trial Evaluating Atz vs. Placebo With Standard Cx + Bev in Ovarian Cancer Patients With Platinum-Sensitive Relapse

By 2024 ESMO Annual Meeting Insights Hub FEATURING Jean-Emmanuel Kurtz
By 2024 ESMO Annual Meeting Insights Hub FEATURING Jean-Emmanuel Kurtz
30 views
September 26, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:30
AstraZeneca Oncology

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

2024 ESMO Annual Meeting Insights Hub: GYN Videos

05:38

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

80 views

·

1 month ago
03:33

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

327 views

·

2 months ago
05:13

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

183 views

·

1 month ago
View All

Recommended

09:06

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

1.6K views

·

4 months ago
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.4K views

·

5 months ago
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

·

7 months ago
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

·

11 months ago
14:45

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

1.0K views

·

5 months ago
08:52

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

442 views

·

2 months ago
11:15

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

436 views

·

8 months ago
13:15

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

421 views

·

4 months ago
04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
15:45

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

534 views

·

6 months ago
27:14

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

439 views

·

5 months ago
06:07

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Insights from 2023 ESMO Annual Meeting

M. Raza Mirza

1.0K views

·

1 year ago
13:14

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…

2024 ESMO Annual Meeting Insights Hub

B. Monk

258 views

·

2 months ago
17:20

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

322 views

·

5 months ago
10:46

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

197 views

·

1 month ago
19:30

Precision Oncology in the Management of Ovarian Cancer

Miami Cancer Institute Precision Oncology Symposium

D. Dizon

270 views

·

5 months ago
23:53

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

276 views

·

5 months ago
06:50

Year in Review: Ovarian Cancer

Fengting Yan

441 views

·

10 months ago
06:02

ESMO 2024 Insights: PRIMA Trial - Newly Diagnosed Advanced Ovarian C…

ecancer

A. González-Martín

137 views

·

1 month ago
07:51

ESMO 2024 Insights: Mirvetuximab Soravtansine-gynx (MIRV) in Platinu…

2024 ESMO Annual Meeting Insights Hub

A. Secord

123 views

·

1 month ago
AUTOPLAY